Insulin glargine and lixisenatide and Phenylephrine and Pyrilamine Tablets
Determining the interaction of Insulin glargine and lixisenatide and Phenylephrine and Pyrilamine Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: phenylephrine / pyrilamine
Brand name: K-Tan, Ryna-12
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Phenylephrine and Thonzylamine
- Insulin glargine and lixisenatide-Phenylephrine and triprolidine
- Insulin glargine and lixisenatide-Phenylephrine Complex
- Insulin glargine and lixisenatide-Phenylephrine Eye Drops 10%
- Insulin glargine and lixisenatide-Phenylephrine Eye Drops 2.5%
- Insulin glargine and lixisenatide-Phenylephrine Hydrochloride
- Phenylephrine and Pyrilamine Tablets-Insulin glargine and lixisenatide Subcutaneous
- Phenylephrine and Pyrilamine Tablets-Insulin glargine, recombinant Subcutaneous
- Phenylephrine and Pyrilamine Tablets-Insulin glulisine
- Phenylephrine and Pyrilamine Tablets-Insulin Glulisine (Cartridges and Pens)
- Phenylephrine and Pyrilamine Tablets-Insulin Glulisine (Vials)
- Phenylephrine and Pyrilamine Tablets-Insulin glulisine Subcutaneous